Picture of Pfizer logo

PFE — Pfizer News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

Astrazeneca's breast cancer drug fails late-stage trial

Astrazeneca's breast cancer drug fails late-stage trial 

- AstraZeneca AZN.L said on Friday its breast cancer drug failed to meet the main goal of improving progression-free survival during a late-stage trial.


(Reporting by Christy Santhosh in Bengaluru; Editing by Tasim Zahid)

((Christy.Santhosh@thomsonreuters.com;))

Recent news on Pfizer

See all news